CIK 0000880242 · Non-accelerated filer<br>Smaller reporting company
BIOLARGO, INC.
Sign in to watch- Ticker
- BLGO
- Exchange
- OTC
- Industry
- Chemicals & Allied Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 650159115
- Phone
- 888 400-2863
- Business address
- 14921 CHESTNUT ST., WESTMINSTER, CA, 92683
- Former names
- NUWAY MEDICAL INC, NUWAY ENERGY INC, LATIN AMERICAN CASINOS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-30 | Runyan John S. Director | Grant or award · Option to Purchase Common Stock | +117,188 | 1,958,302 | ||
| 2020-06-30 | Roberts Kent Charles II Director | Grant or award · Option to Purchase Common Stock | +93,750 | 667,609 | ||
| 2020-06-30 | Marshall Dennis E Director | Grant or award · Option to Purchase Common Stock | +117,188 | 2,901,604 | ||
| 2020-05-01 | PROVENZANO JOSEPH L Secretary | Grant or award · Option to purchase common stock | +50,000 | 1,678,703 | ||
| 2020-05-01 | PROVENZANO JOSEPH L Secretary | Grant or award · Option to purchase common stock | +202,110 | 1,880,813 | ||
| 2020-05-01 | DARGAN CHARLES K Chief Financial Officer | Grant or award · Option to purchase common stock | +7,500 | 3,434,000 | ||
| 2020-05-01 | DARGAN CHARLES K Chief Financial Officer | Grant or award · Option to purchase common stock | +214,286 | 3,648,286 | ||
| 2020-05-01 | CALVERT DENNIS P President | Grant or award · Option to Purchase Common Stock | +50,000 | 3,846,322 | ||
| 2020-05-01 | CALVERT DENNIS P President | Grant or award · Option to purchase common stock | +343,571 | 4,189,893 | ||
| 2020-03-31 | STROMMEN JACK B. Director | Grant or award · Option to Purchase Common Stock | +88,235 | 573,859 | ||
| 2020-03-31 | Roberts Kent Charles II Director | Grant or award · Option to Purchase Common Stock | +88,235 | 573,859 | ||
| 2020-03-31 | Roberts Kent Charles II Director | Grant or award · Option to Purchase Common Stock | +88,235 | 1,604,948 | ||
| 2020-03-31 | Runyan John S. Director | Grant or award · Option to Purchase Common Stock | +110,294 | 1,841,114 | ||
| 2020-03-31 | Marshall Dennis E Director | Grant or award · Option to Purchase Common Stock | +110,294 | 2,784,416 | ||
| 2020-03-31 | CODE KENNETH REAY Chief Science Officer | Grant or award | +366,993 | $0.17 | $62K | 23,755,994 |
| 2020-03-31 | CALVERT DENNIS P President | Grant or award | +281,762 | $0.17 | $48K | 9,139,996 |
| 2020-03-09 | CALVERT DENNIS P President | Gift | −25,000 | 8,858,234 | ||
| 2020-02-25 | DARGAN CHARLES K Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +27,500 | 3,056,500 | ||
| 2020-02-25 | DARGAN CHARLES K Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +400,000 | 3,456,500 | ||
| 2020-02-01 | DARGAN CHARLES K Chief Financial Officer | Other disposition · Option to Purchase Common Stock | −60,000 | 3,029,000 |
Page 10 of 12 · 228 trades